Literature DB >> 22809867

Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.

Ping Zhang1, Jieying Wu, Divino Deoliveira, Nelson J Chao, Benny J Chen.   

Abstract

We studied whether allospecific CD4(+) effector memory T cells (T(EM)) could induce graft-versus-host disease (GVHD) using a novel GVHD model induced solely by CD4(+) T cell receptor transgenic TEa cells. Allospecific T(EM) generated in a lymphopenic host bore a typical memory phenotype. Moreover, these cells were able to elicit a faster and more effective proliferative response on challenge with alloantigen in vitro and to mediate "second-set" skin graft rejection in vivo. However, these allospecific T(EM) were unable to induce GVHD. Allospecific T(EM) recipients became tolerant to alloantigen as a result of clonal deletion. Even though allospecific T(EM) were able to respond to alloantigen initially, the expansion of these cells and inflammatory cytokine production during GVHD were dramatically decreased. The inability of allospecific T(EM) to sustain the alloresponse may be a result of enhanced activation-induced cell death. These observations provide insight into how allospecific CD4(+) T(EM) respond to alloantigen during GVHD and underscore the fundamental differences in alloresponses mediated by allospecific T(EM) in graft rejection and GVHD settings.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22809867      PMCID: PMC3443280          DOI: 10.1016/j.bbmt.2012.07.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  33 in total

1.  Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunity.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Proc R Soc Lond B Biol Sci       Date:  1954-12-15

2.  Naive and memory T cells induce different types of graft-versus-host disease.

Authors:  Suparna Dutt; Diane Tseng; Joerg Ermann; Tracy I George; Yin Ping Liu; Corrine R Davis; C Garrison Fathman; Samuel Strober
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 3.  Prophylaxis and treatment of acute graft-versus-host disease.

Authors:  Nelson J Chao; Benny J Chen
Journal:  Semin Hematol       Date:  2006-01       Impact factor: 3.851

4.  Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides.

Authors:  C E Grubin; S Kovats; P deRoos; A Y Rudensky
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

5.  Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.

Authors:  Benny J Chen; Divino Deoliveira; Xiuyu Cui; Ngocdiep T Le; Jessica Son; John F Whitesides; Nelson J Chao
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells.

Authors:  Britt E Anderson; Anita L Tang; Ying Wang; Monica Froicu; David Rothstein; Jennifer M McNiff; Dhanpat Jain; Anthony J Demetris; Donna L Farber; Warren D Shlomchik; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2011-08-18       Impact factor: 5.532

Review 7.  Homeostasis of naive and memory T cells.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Authors:  David H Chang; Keren Osman; John Connolly; Anjli Kukreja; Joseph Krasovsky; Maggi Pack; Aisha Hutchinson; Matthew Geller; Nancy Liu; Rebecca Annable; Jennifer Shay; Kelly Kirchhoff; Nobusuke Nishi; Yoshitaka Ando; Kunihiko Hayashi; Hani Hassoun; Ralph M Steinman; Madhav V Dhodapkar
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

9.  MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen.

Authors:  G P Spickett; M R Brandon; D W Mason; A F Williams; G R Woollett
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

Review 10.  Plasticity of T cell memory responses to viruses.

Authors:  Liisa K Selin; Raymond M Welsh
Journal:  Immunity       Date:  2004-01       Impact factor: 31.745

View more
  15 in total

Review 1.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 2.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 3.  The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.

Authors:  Motoko Koyama; Geoffrey R Hill
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

4.  PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.

Authors:  Kathryn W Juchem; Faruk Sacirbegovic; Cuiling Zhang; Arlene H Sharpe; Kerry Russell; Jennifer M McNiff; Anthony J Demetris; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

5.  Ceramide synthesis regulates T cell activity and GVHD development.

Authors:  M Hanief Sofi; Jessica Heinrichs; Mohammed Dany; Hung Nguyen; Min Dai; David Bastian; Steven Schutt; Yongxia Wu; Anusara Daenthanasanmak; Salih Gencer; Aleksandra Zivkovic; Zdzislaw Szulc; Holger Stark; Chen Liu; Ying-Jun Chang; Besim Ogretmen; Xue-Zhong Yu
Journal:  JCI Insight       Date:  2017-05-18

6.  SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

Authors:  Jonathan C Poe; Wei Jia; Julie A Di Paolo; Nancy J Reyes; Ji Yun Kim; Hsuan Su; John S Sundy; Adela R Cardones; Victor L Perez; Benny J Chen; Nelson J Chao; Diana M Cardona; Daniel R Saban; Stefanie Sarantopoulos
Journal:  JCI Insight       Date:  2018-10-04

7.  A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

Authors:  Vivian Zhou; Kimberle Agle; Xiao Chen; Amy Beres; Richard Komorowski; Ludovic Belle; Carolyn Taylor; Fenlu Zhu; Dipica Haribhai; Calvin B Williams; James Verbsky; Wendy Blumenschein; Svetlana Sadekova; Eddie Bowman; Christie Ballantyne; Casey Weaver; David A Serody; Benjamin Vincent; Jonathan Serody; Daniel J Cua; William R Drobyski
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

8.  Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.

Authors:  Marie Bleakley; Shelly Heimfeld; Keith R Loeb; Lori A Jones; Colette Chaney; Stuart Seropian; Ted A Gooley; Franziska Sommermeyer; Stanley R Riddell; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2015-06-08       Impact factor: 14.808

9.  Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

Authors:  Kazuhiro Mochizuki; Lijun Meng; Izumi Mochizuki; Qing Tong; Shan He; Yongnian Liu; Janaki Purushe; Henry Fung; M Raza Zaidi; Yanyun Zhang; Ran Reshef; Bruce R Blazar; Hideo Yagita; Shin Mineishi; Yi Zhang
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

10.  Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

Authors:  Qingxiao Song; Xiaoning Wang; Xiwei Wu; Hanjun Qin; Yingfei Li; Arthur D Riggs; Paul J Martin; Yuan-Zhong Chen; Defu Zeng
Journal:  Blood       Date:  2021-04-22       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.